Prevention and PrEP
REACH is focusing efforts to implement and scale-up evidence-based combination prevention efforts, including PrEP (Pre-exposure prophylaxis) and PEP (Post-exposure prophylaxis) that support sexual health and wellbeing.
These efforts are tailored to support the needs and risks of different priority populations. Our goal is to ensure that there is 100% coverage and access to antiretroviral (ARV) medications for prevention (PrEP and PEP) and treatment, whether someone lives in an urban setting or a rural and remote region across Canada.
News + Insights
REACH Nexus’s I’m Ready HIV self-testing research program releases its first data summary
The impact of COVID-19 on our communities: from around the world to Quebec
EPIC project studies impacts of the health crisis caused by COVID-19
Ontario HIV Stigma Index team publishes BMC paper on the health impacts of internalized HIV stigma and depression
Paper’s findings are a valuable contribution to the literature on HIV stigma